The Wnt antagonist DICKKOPF-1 gene is induced by 1α,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells

Carcinogenesis

Volumn 28, Issue 9, 2007, Pages 1877-1884

  Aguilera, Oscar ^a   Peña, Cristina ^b   García, José Miguel ^b   Larriba, María Jesús ^a   Ordóñez morán, Paloma ^a   Navarro, Diego ^a   Barbáchano, Antonio ^a   de Silanes, Isabel López ^c   Ballestar, Esteban ^c   Fraga, Mario F ^c   Esteller, Manel ^c   Gamallo, Carlos ^d   Bonilla, Félix ^b   González Sancho, José Manuel ^a   Muñoz, Alberto ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; GENE PRODUCT; HISTONE; PROTEIN DICKKOPF 1; PROTEIN DKK 1; PROTEIN INHIBITOR; RNA; SEOCALCITOL; UNCLASSIFIED DRUG; UVOMORULIN; VITAMIN D RECEPTOR; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL STRAIN CACO 2; CELL STRAIN HT29; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

CALCITRIOL; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHROMATIN; COLONIC NEOPLASMS; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; POLYMERASE CHAIN REACTION; RNA, NEOPLASM; WNT PROTEINS;

EID: 34848858270     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm094     Document Type: Article

References (47)

1. Lustig,B. et al. (2003) The Wnt signaling pathway and its role in tumor development. J. Cancer Res. Clin. Oncol., 129, 199-221.
2. Logan,C. Y. et al. (2001) The Wnt signaling pathway in development and disease, Annu. Rev. Cell Dev. Biol., 20, 781-810.
3. Reya,T. et al. (2005) Wnt signalling in stem cells and cancer. Nature, 434, 843-850.
4. Cadigan,K.M. et al. (2006) Wnt signaling: Complexity at the surface. J. Cell Sci., 119, 395-402.
5. Moon,R.T. et al. (2004) WNT and β-catenin signalling: Diseases and therapies. Nat. Rev. Genet., 5, 691-701.
6. Kohn,A.D. et al. (2005) Wnt and calcium signaling: β-catenin-independent pathways. Cell Calcium, 38, 439-446.
7. Kawano,Y. et al. (2003) Secreted antagonists of the Wnt signalling pathway. J. Cell Sci., 116, 2627-2634.
8. Bafico,A. et al. (2001) Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat. Cell Biol., 3, 683-686.
9. Mao,B. et al. (2001) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature, 411, 321-325.
10. Mao,B. et al. (2002) Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling. Nature, 417, 664-667.
11. Semenov,M.V. et al. (2001) Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr. Biol., 11, R 92-R 95.
12. Pinto,D. et al. (2003) Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev., 17, 1709-1713.
13. Kuhnert,F. et al. (2004) Essential requirement for Wnt signalling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc. Natl Acad. Sci. USA, 101, 266-271.
14. Gregory,C.A. et al. (2003) The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J. Biol. Chem., 278, 28067-28078.
15. Morvan,F. et al. (2006) Deletion of a single allele of the Dkk-1 gene leads to an increase in bone formation and bone mass. J. Bone Miner. Res., 21, 934-945.
16. Tian,E. et al. (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N. Engl. J. Med., 349, 2483-2494.
17. Christodoulides,C. et al. (2006) The Wnt antagonist Dickkopf-1 and its receptors are co-ordinately regulated during early human adipogenesis. J. Cell Sci., 119, 2613-2620.
18. Wang,J. et al. (2000) Dickkopf-1, an inhibitor of the Wnt signalling pathway, is induced by p53. Oncogene, 19, 1843-1848.
19. Shou,J. et al. (2002) Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitises brain tumor cells to apoptosis following alkylation damage of DNA. Oncogene, 21, 878-889.
20. Ohnaka,K. et al. (2004) Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: Novel mechanims of glucocorticoid-induced osteoporosis. Biochem. Biophys. Res. Commun. 318, 259-264.
21. Lee,A.Y. et al. (2004) Dickkopf-1 antagonizes Wnt signalling independent of β-catenin in human mesothelioma. Biochem. Biophys. Res. Commun., 323, 1246-1250.
22. Mikheev,A.M. et al. (2004) Functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation. Carcinogenesis, 25, 47-59.
23. Aguilera,O. et al. (2006) Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 gene in human colorectal cancer. Oncogene 25, 4116-4121.
24. Niida,A. et al. (2004) DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway. Oncogene, 23, 8520-8526.
25. González-Sancho,J.M. et al. (2005) The Wnt antagonist DICKKOPF-1 gene is a downstream target of β-catenin/TCF and is downregulated in human colon cancer. Oncogene, 24, 1098-1103.
26. Chamorro,M.N. et al. (2005) FGF-20 and DKKI are transcriptional targets of β-catenin and FGF-20 is implicated in cancer and development. EMBO J., 24, 73-84.
27. 3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin. signaling. J. Cell Biol., 154 369-387.
28. Nose,A. et al. (1988) Expressed recombinant cadherins mediate cell sorting in model systems. Cell, 54, 993-1001.
29. Feinberg,A.P. et al. (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132, 6-13.
30. Ballestar,E. et al. (2003) Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer EMBO J., 22, 6335-6345.
31. Pálmer,H.G. et al. (2004) The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat. Med., 10, 917-919.
32. Palacios,J. et al. (1998) Mutations in the β-catenin gene (CTNNB1) in. endometrioid ovarian carcinomas. Cancer Res., 58 1344-1347.
33. Vandesompele,J. et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol., 3, research0034.1-reasearch0034.11.
34. Sancho,E. et al. (2004) Signaling pathways in intestinal development and cancer: Annu. Rev. Cell Dev. Biol., 20, 695-723.
35. Caldwell,G.M. et al. (2004) The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res., 64, 883-888.
36. Suzuki,H. et al. (2004) Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet. 36, 417-422.
37. 3 and its analogs on growth control and tumourigenesis. Front. Biosci., 6, D820-D848.
38. Ordóñez-Morán,P. et al. (2005) Vitamin D and cancer: An update of in vitro and in vivo data. Front. Biosci., 10, 2723-2749.
39. 3 in human colon cancer cells. Anticancer Res., 26, 2669-2681.
40. 3 in human colon cancer cells. Cancer Res., 63, 7799-7806.
41. Shah,S. et al. (2006) The molecular basis of vitamin D receptor and β-catenin crossregulation. Mol. Cell, 22, 799-809.
42. 3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res., 53, 3712-3718.
43. Peña,C. et al. (2005) E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: Clinicopathological correlations. Hum. Mol. Genet., 14, 3361-3370.
44. Cross,H.S. et al. (1996) Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer. Anticancer Res., 16, 2333-2337.
45. Efstathiou,J.A. et al. (1999) Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. Proc. Natl Acad. Sci. USA, 96, 2316-2321.
46. Davis,M.A. et al. (2003) A core function for p120-catenin in cadherin turnover. J. Cell Biol., 163, 525-534.
47. Aono,S. et al. (1999) p120(ctn) acts as an inhibitory regulator of cadherin function in colon carcinoma cells. J. Cell Biol., 145 551-562.